Pitching Endpoints News Cannabis Reporters: Vertical Press Strategy
Endpoints News is a must-win outlet for cannabis biotech, policy, and capital-markets stories. This guide shows how to pitch the Endpoints News Cannabis reporters with precision and speed.
The beat rewards regulatory nuance and financial specificity over lifestyle framing. Lead with the science, the money, or the policy shift.
Editorial Scope: What Endpoints News Covers in Cannabis#
Endpoints News treats cannabis as a pharma-adjacent vertical: clinical trials, FDA scheduling, rescheduling fallout, and capital flows. Your pitch must sit at that intersection.
Consumer trends and dispensary culture rarely land here. Frame every story around regulatory risk, trial data, or market structure.
| Factor | Recommended Strategy | What Gets Ignored |
|---|---|---|
| Story frame | FDA, DEA, rescheduling, trial endpoints | Lifestyle, product reviews, celebrity brands |
| Data | Clinical results, filings, SEC/earnings figures | Anecdotes and single-source claims |
| Timing | Peg to policy actions and earnings dates | Evergreen "state of the industry" pitches |
| Spokespeople | Executives, researchers, regulators | Influencers and dispensary owners |
Identifying Active Writers on the Endpoints News Cannabis Reporters List#
Three-plus journalists actively cover this beat, so route pitches by specialty. Check bylines for who owns policy versus biotech versus finance.
The Endpoints News Cannabis reporters list includes Anna Brown, Jared Whitlock, and Lei Wu as representative writers. Verify current assignments before every send.
💡 Vertical Pro Tip: Match the writer to the angle—policy reporters ignore trial data, and biotech reporters ignore retail policy. A misrouted pitch is a dead pitch at Endpoints.
Angles & Data Points That Resonate With Endpoints News Cannabis Journalists#
Endpoints News Cannabis journalists respond to hard numbers and regulatory consequence. Lead with the "so what" for pharma and investors.
Strong angles include Schedule III implementation, cannabis clinical trial design, and federal-versus-state enforcement gaps. Pair each with primary data.
- New clinical trial results or FDA correspondence
- Rescheduling timelines and tax implications (280E)
- Capital raises, M&A, and earnings surprises
- Enforcement actions and litigation with market impact
Outreach Protocols & Accessing Endpoints News Cannabis Journalists Contacts#
Keep pitches to 150 words with the news hook in the first line. Attach data or link to filings—never bury the lede.
For Endpoints News Cannabis journalists contacts, use verified bylines, the outlet's tip line, and LinkedIn rather than guessing emails. Confirm beat ownership before sending.
Offer exclusives sparingly and only with hard news. Endpoints values access to filings, datasets, and on-record executives.
Fast-Action Pitch Checklist for Cannabis#
- Confirm the writer currently covers cannabis (check recent bylines)
- Lead with regulatory or financial stakes in sentence one
- Include one primary data point or filing link
- Offer an on-record executive or researcher
- Keep it under 150 words with a clear subject line
- Time the send to a policy or earnings catalyst
Build a living Endpoints News Cannabis reporters list and refresh it monthly. Beat assignments shift—stale contacts cost you the story.